$BMY

Bristol-Myers Squibb Company

Bristol-Myers Squibb Company is a large-cap Pharmaceuticals: Major company in the Health Technology sector with a market cap of $121B.

Health Technology Pharmaceuticals: Major stock Stage 2 · Advancing Base 1 Data 25h 45m ago

$59.46 latest close

← Back Join to Watchlist $BMY

Price $59.46

52W High $62.89 -5.5%

52W Low $42.52

Wks Basing 11w

Base Depth -11.9%

Tight Wks 1

Base B1

SMA 50 $58.40

SMA 200 $52.79

Avg Vol 10,960,708

RS Rank 32

RS vs High -15.6%

RS Slope -1.3% ▼

Grp Rank #28/57

ADR% 2.3%

ATR(14) $1.17 (2.0%)

Rel Vol 0.59×

Vol Pace N/A

U/D Vol 0.53

A/D Days 12A / 11D

A/D Rating B

VDU Bars 0/10 d

Earnings 54d

$42.52

$62.89 83%

BMY Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for BMY.

Create Free Account

Setup Quality B 4/7 signals

Score trend

✓ Stage 2 · Advancing ✗ Power Trend ✗ RS New High ✓ Trend 7/8 ✗ No Pattern ✓ CANSLIM 79.6 (A) ✓ Gatekeeper Base #1 (A)

See the full conviction stack.

Unlock Insights

Legend Scorecard 6 methodology checks

Council consensus: 🟡 4 of 6 legends are Watching — building, not yet a confirmed buy.

Minervini

Watch

B 9/12

Ask →

O'Neil

Avoid

C 4/7

Ask →

Weinstein

Avoid

C 4/7

Ask →

Livermore

Watch

B 2/4

Ask →

Darvas

Watch

B 2/4

Ask →

Wyckoff

Watch

B 2/4

Ask →

Breakout Health

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

Unlock Follow-Through Tracking

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▼ Falling

Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net -2 B

Minervini · Grade Card

SEPA — Specific Entry Point Analysis · 5/7 criteria met

B 5/7 SEPA

✓ EPS acceleration ≥25% QoQ +25%

✗ Revenue growth ≥20% YoY -0%

✓ Gross margin ≥30% 54%

✓ ROE ≥17% 42%

✗ RS rating ≥80 (price leadership) 62

✓ Stage 2 uptrend (Weinstein) Stage 2

✓ Within 25% of 52W high -5.5%

Pattern Analysis (historical · 11d ago)

Basing

68.8 score

RS Score 62

Trend 7/8 ✓

CANSLIM 79.6 (A)

base type: Flat Base depth: 0.119 duration weeks: 12.0 tightness: 0.0269 near pivot: ✓ validation reason: valid basing setup multi tf reason: weekly: above 30W MA + no fresh 13-week low

Why This Setup? D+W Confluence

Basing

Minervini Trend Template

7/8

Price above SMA 150 & 200 $59.46 vs SMA150 $55.03 / SMA200 $52.79

SMA 150 above SMA 200 SMA150 $55.03 vs SMA200 $52.79

SMA 200 trending up Slope +1.07 over 20 days

SMA 50 above SMA 150 & 200 SMA50 $58.40

Price above SMA 50 $59.46 vs SMA50 $58.40

30%+ above 52W low +39.8% from $42.52

Within 25% of 52W high -5.5% from $62.89

RS score above 70 RS 62

Fundamentals

52W Range

83%

Mkt Cap SEC

121.4B

EPS QoQ

+25%

Rev YoY

-0%

ROE

42%

Gross Margin

54%

D/E

2.44

EPS TTM

$3.46

P/E TTM

17.2x

Float

2.0B

Insider

No Buy

Company

O'Neil · Grade Card

CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market

A 79.6 CANSLIM

C · Curr. EPS

A · Annual EPS

N · New Highs

100

S · Supply/Demand

L · Leader RS

I · Inst. Spons.

100

M · Market

100

Weekly Context

Multi-timeframe signals from weekly bars

W. Trend

3/8

W. RS

W. Support

$47.58

W. Resist

$62.89

W. Patterns

Cup & Handle

Weekly Structure

Trend Falling

Tight Weeks 1

Confirmation Bearish

Scan History

May 26

Basing ✓ Gate

May 26

Basing ✓ Gate

May 25

Basing ✓ Gate

May 25

Basing ✓ Gate

May 25

Basing ✓ Gate

May 22

Basing ✓ Gate

68 0.0%

Position Sizer

Full Calculator →

Account Size ($) Risk per Trade (%) Entry Price ($) Stop Price ($)

ATR(14) stop suggestions:

Get the full picture on BMY

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 495+ symbols daily.

Start 7-Day Free Trial